Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. - Wikidata - wikimedia - TriplyDB

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

http://www.wikidata.org/entity/Q33831797

about

Antibiotics for treating community acquired pneumonia in people with sickle cell disease Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries Micro- and nanodevices integrated with biomolecular probes.Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients Chronic complications and quality of life of patients living with sickle cell disease and receiving care in three hospitals in Cameroon: a cross-sectional study.A call for policy action in sub-Saharan Africa to rethink diagnostics for pregnancy affected by sickle cell disease: differential views of medical doctors, parents and adult patients predict value conflicts in Cameroon.Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania.Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania.Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria Health policy for sickle cell disease in Africa: experience from Tanzania on interventions to reduce under-five mortality.Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia.Deaths from Sickle Cell Disease in Intensive Care Units: Can we do better?Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.Optical characterization of red blood cells from individuals with sickle cell trait and disease in Tanzania using quantitative phase imaging.Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania.Sickle cell anemia: iron availability and nocturnal oximetry.Haematology in Africa.Quantitative MRI analysis of salivary glands in sickle cell disease.Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania Hematological and Genetic Predictors of Daytime Hemoglobin Saturation in Tanzanian Children with and without Sickle Cell Anemia.Family, Community, and Health System Considerations for Reducing the Burden of Pediatric Sickle Cell Disease in Uganda Through Newborn Screening Sickle cell disease in Africa: a neglected cause of early childhood mortality Physiology and pathophysiology of iron in hemoglobin-associated diseases.Complications of sickle cell anaemia in children in Northwestern Tanzania.Morbidity pattern in hospitalized under five children with sickle cell disease.Neurological complications of sickle cell disease in Africa: protocol for a systematic review Prognostic factors in relation to racial disparity in advanced colorectal cancer survival.Mortality by sickle cell disease in Brazil.A Paper-Based Test for Screening Newborns for Sickle Cell Disease.The challenge of haemoglobinopathies in resource-poor countries.Psychosocial burden of sickle cell disease on parents with an affected child in Cameroon.Management of sickle cell disease in the community.Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania.Emerging point-of-care technologies for sickle cell disease screening and monitoring.Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.High rate of sickle cell anaemia in Sub-Saharan Africa underlines the need to screen all children with severe anaemia for the disease.How we manage iron overload in sickle cell patients.Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.

P2860

Q24197977-9B51828E-B40C-47AF-97BF-BB04810956E5 Q24604028-CEA165E9-551D-44E6-8096-22AA113B2472 Q26781371-4294AC36-EE8A-4185-BA3B-D3B2DA2FAC30 Q27016104-592CBAB5-068B-407A-A134-F9C2275667D6 Q33587595-5E8E0C76-C1E8-44D7-9953-FFA647BAD4A7 Q33861110-2F7CC613-B8E6-4BE0-911F-B2982CF538A3 Q34590161-20290A2F-EEF2-4AAB-9431-A70F78DD8D66 Q35082491-8C5FFCCB-53E6-468B-91EF-1CF0A56723B3 Q35576807-5E01A50F-3FA2-4781-BBD1-28C4C326C213 Q35597882-27842A42-6733-42FF-952F-2FD584D541D6 Q35659874-D5CE5229-E3CD-4867-98D0-66B051C89CB6 Q35886753-63B4BB53-6DCC-44D4-9E3F-39E3EC395BBB Q35891916-688895B3-55C0-4C86-97E1-F9D336701576 Q36086761-EEAC9396-6DE4-43BC-B3F8-DF756E672D2C Q36108613-83460342-959E-4343-9006-4DDAFBD7EAD0 Q36166540-BD789091-C926-4B44-90FE-7EE382F4137E Q36282455-61B14B5C-56C0-4ADF-8F27-F3DBFEA69C2B Q36316099-1B7D2C01-C4AE-4299-B0CD-DE9248A884FB Q36482598-5D1FAC20-D208-475B-8815-8286EDAD0F9E Q36532564-CE7CF704-F978-4C89-86D7-93A79BB057B9 Q36554542-1A5F6167-A969-40A6-98FE-C6016B49D71A Q36830041-32C055D6-E75E-46D3-B7EC-0F6C631209A1 Q36997654-E49A8883-7205-4D4D-85EC-12BAB261DC5F Q37001823-D6EB9A1E-6B23-4B2C-9AE3-30CFF8CE9F81 Q37082896-E61DB4C2-B09A-40D5-B565-C91B4D0B0CD2 Q37149765-2090575B-3B10-41E0-A012-2CBBDD0FE0F8 Q37282716-134BB68D-FFD6-418E-B830-651A1C2932A9 Q37355968-7485D06C-272E-4347-929E-E07C6212470B Q37394330-25833E62-C4FC-4CAB-A87A-959DBE0FFE26 Q37683303-11D282E1-6272-4E67-BDCC-50B5C83B0712 Q37734681-7ABBF7DA-B2FA-4A24-8FCA-DDC27488A38E Q37897246-51D4A64A-E565-481E-946C-B7C37401F875 Q38123725-55EFA49C-E7FD-484E-9304-53C60FD5C420 Q38194789-E976C83F-DE05-45BB-B268-D3B940FF7CE8 Q38606802-7B1EAE5C-1E9A-4339-AC75-BC9A43DAC257 Q38804432-8EBE2FDA-AF11-481D-B7C8-1E7868B81A70 Q39007637-1D160EF4-2DCC-4F01-B4D7-30D30017510C Q39114870-1B6AE1F8-7733-4DA1-B195-844BAD19CBF4 Q39179372-00D87DB1-02C3-40EF-B4BF-7795656FF71F Q39179409-09DDCBA4-0270-493F-B32A-66988915A477

P2860

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

http://www.wikidata.org/entity/Q33831797

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@ast

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@en

type

label

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@ast

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@en

prefLabel

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@ast

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@en

P1433

Q33831797-85093362-382E-4219-8C5D-5F641004CDAA

P1476

Q33831797-018F90F2-C53E-42D4-966F-117B56BAC2F5

P2093

Q33831797-0E74BF6E-2A6C-4C2E-9F48-F269604EC15D

Q33831797-0FF39F82-578C-4A6F-91B3-04247720B2D7

Q33831797-153591AE-F33F-4A26-A5A4-BA65306EF97C

Q33831797-272A5F34-F0D0-412E-9EB6-31BBD92EC902

Q33831797-2838EEEC-E2C6-4416-85FF-CA4E968DF7B8

Q33831797-30AD8AB0-B8DC-4DCE-B38E-BC6798471567

Q33831797-32EABA1A-E65F-4D59-80CE-9AEEE6461F84

Q33831797-64141683-D07C-466B-915E-7BE41781C44D

Q33831797-6C6E2A7F-83EA-46A6-B291-6E630A30CBC6

Q33831797-AE579D45-70D1-4EFA-BD97-E5B6E35D4B4F

P2860

Q33831797-0F7AE27F-3D64-4BC4-92A8-57A285552E6B

Q33831797-19A9A5D6-64AC-4749-BD37-D82809CC4A0E

Q33831797-2158A787-9680-4F2F-8CE7-D7F12C434C0D

Q33831797-25228C71-BBAF-4046-8DE3-81BB079324A5

Q33831797-2EBF8D01-C7B5-4044-865B-32E908934C29

Q33831797-30D38495-0D7D-4C03-85B2-1B5500DC31D0

Q33831797-38FC84C8-68DC-4150-B6C7-7ED5BCECA879

Q33831797-4AE92423-20ED-4A13-A9CF-61BD4FD1F383

Q33831797-55F56D3F-EC0A-4073-8D5B-15BE6B2DEFD3

Q33831797-5ED82C9B-9E3B-406C-86F8-9AB8AE72D111

P304

Q33831797-BB17BA22-BD19-4CEA-813E-51750E06AA7E

P31

Q33831797-576270CF-F8A0-468C-99C1-CFDBB2C7AC8C

P356

Q33831797-7E04A3E5-E841-40A2-B0DB-A2851A6C1E67

P407

Q33831797-794798BA-9E01-4A43-ADFD-70DF04AC5824

P433

Q33831797-84EA1CD2-D26B-47F6-8404-3003128FA7E8

P478

Q33831797-F4F2650A-A62A-42ED-9197-CA675CD3737C

P50

Q33831797-20F13393-BFA5-4ABF-AC9C-419A6817FF6D

Q33831797-248FF99E-7443-4240-89E5-D917BE202A2F

Q33831797-48435020-7D37-4A69-91F9-52AB6807BC5F

Q33831797-8CB65147-8B55-4A9A-891B-60D9EA417422

Q33831797-BC734B7C-2B9C-4715-A9B1-7F3D8BB5CF0C

Q33831797-C8AF07F6-AE0C-4970-99CE-9C1E2A06176E

Q33831797-D821CA7D-BB69-4615-868E-12839DBDE930

Q33831797-F9943033-A148-469D-BE7E-887105E6607B

P577

Q33831797-C2AAEFD9-0D8A-4722-9437-7C47731FBEBF

P5875

Q33831797-10F60781-C2BE-4FC7-8891-FFF10AA0A6ED

P698

Q33831797-94CE0631-4002-4DAE-A19C-ECB46C9391A8

P921

Q33831797-55B184D9-3E3C-451D-B128-52BB8552D7AA

Q33831797-858B2544-2B0F-4970-A539-B51D5977D9D2

P932

Q33831797-6F4A4422-4AE3-49B6-B4C6-08546EEE28F3

P356

JOURNAL.PONE.0014699

P1433

P1476

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.

@en

P2093

Albert N Komba

http://www.w3.org/2001/XMLSchema#string

Brett Lowe

http://www.w3.org/2001/XMLSchema#string

David J Roberts

http://www.w3.org/2001/XMLSchema#string

David Muturi

http://www.w3.org/2001/XMLSchema#string

Deogratius Soka

http://www.w3.org/2001/XMLSchema#string

Elineema Meda

http://www.w3.org/2001/XMLSchema#string

Hadija Mwamtemi

http://www.w3.org/2001/XMLSchema#string

Jesse Kitundu

http://www.w3.org/2001/XMLSchema#string

Julie Oruo

http://www.w3.org/2001/XMLSchema#string

Kisali Pallangyo

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain

Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study.

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Causes of death in sickle-cell disease in Jamaica

Types of anaemic crises in paediatric patients with sickle cell anaemia seen in Enugu, Nigeria.

Survival of children with sickle cell disease.

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?

Global epidemiology of haemoglobin disorders and derived service indicators.

Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.

P304

e14699

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0014699

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Charles R. Newton

Fenella J. Kirkham

Thomas N Williams

Josephine Mgaya

P577

2011-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50227878

http://www.w3.org/2001/XMLSchema#string

P698

21358818

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3040170

http://www.w3.org/2001/XMLSchema#string